|
Volume 270,
Number 7,
Issue of February 17, 1995 pp. 3001-3011
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Endogenous
Retinoic Acid Receptor (RAR)-Retinoid X Receptor (RXR) Heterodimers Are
the Major Functional Forms Regulating Retinoid-responsive Elements in
Adult Human Keratinocytes
BINDING OF LIGANDS TO RAR ONLY IS SUFFICIENT FOR RAR RXR
HETERODIMERS TO CONFER LIGAND-DEPENDENT ACTIVATION OF hRAR 2/RARE
(DR5)
(Received for publication, September 9, 1994)
Jia-Hao
Xiao ,
Béatrice
Durand
,
Pierre
Chambon
,
John
J.
Voorhees
We have examined how retinoic acid receptors (RARs) and retinoid
X receptors (RXRs) at physiological concentrations regulate distinct
retinoid-responsive elements, hRAR 2/ RARE (DR5) and
rCRBPII/RXRE (DR1), in keratinocytes from human skin, a major retinoid
target. In vitro, endogenous RAR and RXRs bound to these
elements as heterodimers (RAR RXR) but not homodimers
(RAR RAR or RXR RXR). In cultured keratinocytes,
all-trans retinoic acid, 9-cis retinoic acid, and
CD367 activated RARE but not RXRE via endogenous RAR RXR
(ED = 2.3, 3.8, and 0.3 nM, respectively)
whereas SR11237 showed no significant effect. All-trans retinoic acid, 9-cis retinoic acid, and SR11237 activated
RXRE via overexpressed RXR RXR (ED = 110, 120,
and 11 nM, respectively), indicating interconversion between
retinoic acid isomers, whereas co-overexpression of RAR or
RAR suppressed this activation. Unlike 9cRA, CD367 neither induced
formation of nor activated RXR RXR. Overexpression of RAR or RXR
mutated in transactivation domain AF-2 suppressed endogenous receptor
activity over RARE. Our data suggest that 1) in keratinocytes,
RAR RXR-mediated pathway dominates over that mediated by
RXR RXR; 2) RAR-selective CD367 and RXR-selective SR11237 can be
used to identify these two distinct pathways, respectively; 3)
RARE is mainly regulated by RAR RXR, in which RAR alone
confers ligand inducibility whereas AF-2 of unliganded RXR is required
for transactivation by liganded RAR AF-2; 4) lack of RXRE activity in
keratinocytes is due to low endogenous levels of RXR RXR and
inhibition by RAR RXR; and 5) interaction among RXRs is much lower
than that between RAR and RXR.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G.M. Ledda-Columbano, M. Pibiri, F. Molotzu, C. Cossu, L. Sanna, G. Simbula, A. Perra, and A. Columbano
Induction of hepatocyte proliferation by retinoic acid
Carcinogenesis,
November 1, 2004;
25(11):
2061 - 2066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Y. Park, I. J. Cho, and S. G. Kim
Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Heterodimer
Cancer Res.,
May 15, 2004;
64(10):
3701 - 3713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Varani, P. Perone, M. G. Merfert, S. E. Moon, D. Larkin, and M. J. Stevens
All-trans Retinoic Acid Improves Structure and Function of Diabetic Rat Skin in Organ Culture
Diabetes,
December 1, 2002;
51(12):
3510 - 3516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-C. Xu, W. Y. L. Wong, L. Goldberg, S. C. Baer, J. E. Wolf, W. M. Ramsdell, D. S. Alberts, S. M. Lippman, and R. Lotan
Progressive Decreases in Nuclear Retinoid Receptors during Skin Squamous Carcinogenesis
Cancer Res.,
June 1, 2001;
61(11):
4306 - 4310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wan, W. K. Hong, and R. Lotan
Increased Retinoic Acid Responsiveness in Lung Carcinoma Cells that Are Nonresponsive Despite the Presence of Endogenous Retinoic Acid Receptor (RAR) {beta} by Expression of Exogenous Retinoid Receptors Retinoid X Receptor {{alpha}}, RAR{{alpha}}, and RAR{{gamma}}
Cancer Res.,
January 1, 2001;
61(2):
556 - 564.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. A. Hansen, C. C. Sigman, F. Andreola, S. A. Ross, G. J. Kelloff, and L. M. De Luca
Retinoids in chemoprevention and differentiation therapy
Carcinogenesis,
July 1, 2000;
21(7):
1271 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Sun, P. Yue, L. Mao, M. I. Dawson, B. Shroot, W. W. Lamph, R. A. Heyman, R. A. S. Chandraratna, K. Shudo, W. K. Hong, et al.
Identification of Receptor-selective Retinoids That Are Potent Inhibitors of the Growth of Human Head and Neck Squamous Cell Carcinoma Cells
Clin. Cancer Res.,
April 1, 2000;
6(4):
1563 - 1573.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X.-Y. Li, M. Boudjelal, J.-H. Xiao, Z.-H. Peng, A. Asuru, S. Kang, G. J. Fisher, and J. J. Voorhees
1,25-Dihydroxyvitamin D3 Increases Nuclear Vitamin D3 Receptors by Blocking Ubiquitin/Proteasome-Mediated Degradation in Human Skin
Mol. Endocrinol.,
October 1, 1999;
13(10):
1686 - 1694.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Mouchon, M.-H. Delmotte, P. Formstecher, and P. Lefebvre
Allosteric Regulation of the Discriminative Responsiveness of Retinoic Acid Receptor to Natural and Synthetic Ligands by Retinoid X Receptor and DNA
Mol. Cell. Biol.,
April 1, 1999;
19(4):
3073 - 3085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Thacher, S. Nagpal, E. S. Klein, T. Arefieg, G. Krasinski, D. DiSepio, C. Agarwal, A. Johnson, R. L. Eckert, and R. A. S. Chandraratna
Cell Type and Gene-specific Activity of the Retinoid Inverse Agonist AGN 193109: Divergent Effects from Agonist at Retinoic Acid Receptor {{gamma}} in Human Keratinocytes
Cell Growth Differ.,
April 1, 1999;
10(4):
255 - 262.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. E. Folkers, B. van der Burg, and P. T. van der Saag
Promoter Architecture, Cofactors, and Orphan Receptors Contribute to Cell-specific Activation of the Retinoic Acid Receptor beta 2 Promoter
J. Biol. Chem.,
November 27, 1998;
273(48):
32200 - 32212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wan, M. I. Dawson, W. K. Hong, and R. Lotan
Overexpressed Activated Retinoid X Receptors Can Mediate Growth Inhibitory Effects of Retinoids in Human Carcinoma Cells
J. Biol. Chem.,
October 9, 1998;
273(41):
26915 - 26922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Solomon, M. Sebag, J. H. White, J. Rhim, and R. Kremer
Disruption of Vitamin D Receptor-Retinoid X Receptor Heterodimer Formation following ras Transformation of Human Keratinocytes
J. Biol. Chem.,
July 10, 1998;
273(28):
17573 - 17578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Thacher, A. M. Standeven, J. Athanikar, S. Kopper, O. Castilleja, M. Escobar, R. L. Beard, and R. A. S. Chandraratna
Receptor Specificity of Retinoid-Induced Epidermal Hyperplasia: Effect of RXR-Selective Agonists and Correlation with Topical Irritation
J. Pharmacol. Exp. Ther.,
August 1, 1997;
282(2):
528 - 534.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. S. Attar, P. W. Wertz, M. McArthur, S. Imakado, J. R. Bickenbach, and D. R. Roop
Inhibition of Retinoid Signaling in Transgenic Mice Alters Lipid Processing and Disrupts Epidermal Barrier Function
Mol. Endocrinol.,
June 1, 1997;
11(6):
792 - 800.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X Feng, Z H Peng, W Di, X Y Li, C Rochette-Egly, P Chambon, J J Voorhees, and J H Xiao
Suprabasal expression of a dominant-negative RXR alpha mutant in transgenic mouse epidermis impairs regulation of gene transcription and basal keratinocyte proliferation by RAR-selective retinoids.
Genes & Dev.,
January 1, 1997;
11(1):
59 - 71.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fisher, M. Blumenberg, and M. Tomic-Canic
Retinoid Receptors and Keratinocytes
Critical Reviews in Oral Biology & Medicine,
January 1, 1995;
6(4):
284 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|